163 related articles for article (PubMed ID: 11376039)
1. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
[TBL] [Abstract][Full Text] [Related]
2. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
3. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
Araujo S; Goulart LR; Truman RW; Goulart IMB; Vissa V; Li W; Matsuoka M; Suffys P; Fontes AB; Rosa PS; Scollard DM; Williams DL
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560
[TBL] [Abstract][Full Text] [Related]
4. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
Chen X; He J; Liu J; You Y; Yuan L; Wen Y
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007946. PubMed ID: 31881061
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
Nakata N; Kai M; Makino M
Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
[TBL] [Abstract][Full Text] [Related]
6. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
7. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
[TBL] [Abstract][Full Text] [Related]
9. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
11. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
Gillis TP; Williams DL
Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
[TBL] [Abstract][Full Text] [Related]
12. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
13. [DNA microarray based rapid drug susceptibility test for Mycobacterium leprae].
Suzuki Y; Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):271-7. PubMed ID: 17037383
[TBL] [Abstract][Full Text] [Related]
14. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
Marijke Braet S; Jouet A; Aubry A; Van Dyck-Lippens M; Lenoir E; Assoumani Y; Baco A; Mzembaba A; Cambau E; Vasconcellos SEG; Rigouts L; Suffys PN; Hasker E; Supply P; de Jong BC
Lancet Microbe; 2022 Sep; 3(9):e693-e700. PubMed ID: 35850123
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
[TBL] [Abstract][Full Text] [Related]
16. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
17. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
18. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
[TBL] [Abstract][Full Text] [Related]
19. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.
Levy L; Peters JH
Antimicrob Agents Chemother; 1976 Jan; 9(1):102-12. PubMed ID: 769667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
